BBIO Market Cap & Key Metrics
BridgeBio Pharma, Inc.
$67.15
+$2.20(+3.40%)
36
Overall
40
Value
18
Tech
52
Quality
Market Cap
$12.69B
Volume
1.06M
52W Range
$52.75 - $93.42
Target Price
$108.35
BBIO market cap is $12.69B. This page lists BridgeBio Pharma, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
BBIO Key Metrics
- Market cap
- $12.69B
- EPS estimate, current year
- $-2.66
- EPS growth, 3-year
- -5.06%
- Value score
- 40
- Quality score
- 52
- Technical score
- 18
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $502.08M | $221.90M | $9.30M | $77.65M | $69.72M |
| EBITDA | -$663.10M | -$433.55M | -$565.47M | -$397.44M | -$533.83M |
| EPS | $-3.78 | $-2.88 | $-3.95 | $-3.26 | $-3.90 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BBIO | $67.15 | +3.4% | 1.06M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |